[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1991

Microalbuminuria in Clinical Practice

Author Affiliations

From the Division of Endocrinology and Metabolism (Drs Mc-Kenna, Arias, and Whitehouse), and the Radioligand Laboratory (Dr Feldkamp), Henry Ford Hospital, Detroit, Mich.

Arch Intern Med. 1991;151(9):1745-1747. doi:10.1001/archinte.1991.00400090047009
Abstract

Albumin excretion rate measured by new immunoassays and semiquantitative tests is advocated as a means for early detection of diabetic nephropathy. We determined albumin excretion rate in 276 patients. Albumin excretion rate was normal in 66%, within the microalbuminuric range in 27%, and within the macroproteinuric range in 7%. Significant predictors of albumin excretion rate included presence of hypertension and glycosylated hemoglobin level in type I diabetes mellitus, and years since diagnosis in type II diabetes mellitus. A semiquantitative test was deemed to be of limited diagnostic value. We conclude that testing for early diabetic nephropathy in routine clinical practice gives valuable information and that determination by a quantitative immunoassay based on a single 24-hour urine sample is preferable. The optimal frequency of screening and the levels that determine progressive renal disease have yet to be established.

(Arch Intern Med. 1991;151:1745-1747)

×